Press Releases Theralase Provides Company Update on Phase II Bladder Cancer Clinical StudyMarch 20, 2020Theralase Advances its Pivotal Phase II Non-Muscle Invasive Bladder Cancer Study with a New Clinical Study Site in Nova ScotiaFebruary 25, 2020Theralase Technologies Awarded 2020 TSX Venture 50February 20, 2020Theralase Granted US Patent for Multiwavelength Photodynamic TherapyJanuary 27, 2020Theralase Wins Precedent-Setting Lawsuit Against Anonymous Individuals for Posting Defamatory Comments OnlineJanuary 16, 2020Theralase Releases Quarterly NewsletterJanuary 07, 2020Theralase Releases Third Quarter 2019 Financial Results and Company UpdateNovember 29, 2019Theralase Researchers Receive Recognition for Recent Scientific PublicationsNovember 27, 2019Theralase Announces Leadership TransitionOctober 31, 2019Theralase Granted European Patent for Anti-Cancer Photo Dynamic CompoundsOctober 22, 2019London Health Sciences Centre Launches as Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyOctober 07, 2019Theralase Files Investigational New Drug Application with the FDAOctober 01, 2019Patient Six Cancer-Free Eighteen Months After Single Anti-Cancer TreatmentSeptember 30, 2019Theralase Grants Stock OptionsSeptember 16, 2019Theralase Announces First Patient Treated in Phase II Non-Muscle Invasive Bladder Cancer Clinical StudySeptember 04, 2019Theralase Releases Second Quarter 2019 Financial Results and Company UpdateAugust 29, 2019THERALASE ANNOUNCES CLOSING OF PROSPECTUS OFFERING FOR GROSS PROCEEDS OF $17,250,000August 22, 2019Patient Five Cancer-Free Eighteen Months After Single Anti-Cancer TreatmentJuly 31, 2019McGill University Health Centre Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyJuly 30, 2019Theralase Enrolls First Patient into Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyJuly 29, 2019123…11Next » We exhibit at .. Discover our Therapeutic Lasers Read our latest blog articles .. Developing a Potential Cure for Bladder Cancer Theralase – Participating in Bladder Cancer Walk 2019 Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment Active Rehabilitation – How Much is Too Much? Speeding up Athletes’ Recovery ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Theralase Laser Technology – The Magic Lamp? ✴ Guest blog post by Dr. JAMES W. GREGG, D.C. Treating Sports-Related Ankle Sprains Natural, Drug-free Pain Management ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Are Soccer Moms Now the Candidates Most Likely to Succumb to Drug Addiction? Everything You Need To Know About Class 3 vs. Class 4 123
